Patent 12303166

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-flash

No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.

Cases on file (0)

Specific litigation cases in our database that name US patent 12303166. The free-form analysis below may also discuss cases beyond this list.

No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

The US Patent 12303166 is currently involved in litigation.

Here are the details of the known litigation:

  • Plaintiff(s): Boston Scientific Corporation and Relievant Medsystems, Inc.

  • Defendant(s): Stryker Corporation

  • Jurisdiction: U.S. District Court for the District of New Jersey (initial denial of preliminary injunction), and U.S. Court of Appeals for the Federal Circuit (CAFC) (affirmation of denial)

  • Case Number:

    • District Court: 25-cv-12700 (New Jersey District Court)
    • CAFC: 26-1171 (Court of Appeals for the Federal Circuit)

  • Filing Date: July 2, 2025 (District Court)

  • Outcome/Current Status: The U.S. District Court for the District of New Jersey denied a preliminary injunction sought by Boston Scientific Corp. and Relievant Medsystems, Inc. to prevent Stryker Corporation's launch of its OptaBlate BVN spinal ablation device. This denial was affirmed by the U.S. Court of Appeals for the Federal Circuit (CAFC) in a decision issued on June 17, 2026. Boston Scientific had argued that Stryker would induce physicians to infringe claims 16 and 21 of the '166 patent. The CAFC concluded that Boston Scientific had not demonstrated a likelihood of success on the merits.Known litigation involving US patent 12303166 includes the following case:

  • Plaintiff(s): Boston Scientific Corporation and Relievant Medsystems, Inc.

  • Defendant(s): Stryker Corporation

  • Jurisdiction:

    • U.S. District Court for the District of New Jersey
    • U.S. Court of Appeals for the Federal Circuit (CAFC)

  • Case Number:

    • District Court: 2:25-cv-12700
    • CAFC: 26-1171

  • Filing Date: July 2, 2025 (District Court)

  • Outcome or Current Status: The U.S. District Court for the District of New Jersey denied a preliminary injunction sought by Boston Scientific Corp. and Relievant Medsystems, Inc. against Stryker Corporation's OptaBlate BVN spinal ablation device. This denial was affirmed by the U.S. Court of Appeals for the Federal Circuit (CAFC) in a decision issued on June 17, 2026. Boston Scientific argued that Stryker's product induced infringement of claims 16 and 21 of the U.S. Patent No. 12,303,166. The CAFC found that Boston Scientific had not demonstrated a likelihood of success on the merits, particularly regarding the doctrine of equivalents infringement.

Generated 6/18/2026, 12:00:51 AM